Roche and DxS Ltd. have signed an exclusive distribution agreement for the DxS TheraScreen K-RAS Mutation Test and TheraScreen EGFR 29 Mutation Test. The tests are intended, when considered with other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback